香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 就 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 註冊成立一家全資附屬公司 本公告由Home Control International Limited（「本公司」，連 同 其 附 屬 公 司 統 稱「本 集 團」）自 願 刊 發，旨 在 就 本 集 團 業 務 拓 展 及 品 牌 形 象 升 級 事 項 向 本 公 司 股 東（「股 東」）及 潛 在 投 資 者 提 供 最 新 資 料。於 二 零 二 五 年 九 月 十 二 日，本 公 司 董 事（「董 事」）會（「董事會」）議 決 推 行 其 業 務 擴 展 方 案 及 相 應 的 品 牌 重 塑 工 作。就 前 文 所 述，董 事 會 欣 然 宣 佈，本 集 團 已 啟 動 其 在 醫 療 保 健 領 域 的 戰 略 性 佈 局 以 把 握 市 場 機 遇，且 作 為 起 步，已 在 香 港 成 立 一 家 全 資 附 屬 公 司（「香港附 ...

Core Insights - The report provides a comprehensive analysis of Koninklijke Philips N.V., detailing its history, product offerings, technologies, major applications, and end-user industries served [1][2]. Company Background - Koninklijke Philips N.V. has a 130-year heritage of innovation aimed at addressing global health challenges [2]. - The company holds an extensive intellectual property portfolio, including approximately 50,500 patent rights, 150,000 design rights, 30,500 trademarks, and 3,200 domain names [2]. - Philips operates as a parent company of The Philips Group, with an operating model that promotes agility and sustainable impact [2]. Business Segments - Philips operates through four major segments: diagnosis and treatment, connected care, personal health, and others, which includes six major businesses [3]. - The company emphasizes diversification from consumer products to the healthcare industry through innovation, design, and sustainability [3]. - Philips is organized into three operational regions: North America, Greater China, and the international region, while financial calculations are segmented into four regions: Western Europe, North America, Other mature geographies, and Growth geographies [3]. Financial Performance - The report evaluates Philips's financial performance over the past three years, including a strategic analysis of recent developments such as mergers, acquisitions, partnerships, and product launches [4]. - It discusses the company's R&D expenditure from 2023 to 2025, focusing on key areas and technological breakthroughs [4]. Strategic Analysis - The report includes a SWOT analysis to assess the micro and macro environment affecting the company's growth trajectory [5]. - It maps out a list of distributors across regions and evaluates strategic alliances, M&A activity, and development outlook over the past three years [5]. Key Topics Covered - The report includes a detailed company profile, financial outlook for the last three fiscal years, and an overview of sustainability trends and ESG developments [9][14]. - It provides insights into the company's mission, vision, leadership, business segments, and product offerings [9].

Market Overview - The global anesthesia devices market is estimated to be valued at US$17.1 billion in 2024 and projected to reach US$27.3 billion by 2030, registering a CAGR of 8.1% from 2024 to 2030 [1][14]. Market Drivers - The market is driven by the increasing number of surgical procedures, particularly in cardiology, neurology, and orthopedics, alongside the rising prevalence of chronic illnesses and age-related conditions in the geriatric population [2][4]. - High-impact injuries from accidents have led to a surge in orthopedic surgeries requiring anesthesia [2]. Technological Advancements - Innovations in anesthesia delivery systems, such as real-time monitoring and automated dosing, are enhancing patient safety and operational efficiency [4][10]. Regional Analysis - North America holds the largest share of the global anesthesia devices market at 40.8% in 2024, driven by a sophisticated healthcare system and high rates of surgical procedures [5]. - The Asia-Pacific region is experiencing the fastest growth, with a projected CAGR of over 10% during 2024-2030, supported by improvements in healthcare infrastructure and rising surgical numbers [6]. Product Segmentation - The market is segmented into anesthesia delivery machines, disposables & accessories, monitors, and anesthesia information management systems (AIMS), with anesthesia delivery machines accounting for 37.5% of the market share in 2024 [7]. - The anesthesia monitors segment is projected to grow the fastest with a CAGR of 9.4% from 2024 to 2030 [8]. Application Segmentation - The orthopedics segment leads the market with a 22.2% share in 2024, attributed to the rising incidence of orthopedic conditions [9]. - Cardiology is the most rapidly expanding segment within the anesthesia devices market, with a CAGR of 9.7% from 2024 to 2030, driven by the prevalence of cardiovascular illnesses and an increasing number of cardiac surgeries [10].

Market Overview - The global ultrasound image analysis software market is estimated to be USD 0.913 billion in 2024 and is expected to reach USD 2.20 billion by 2035, with a CAGR of 8.34% during the forecast period 2025-2035 [1][17]. Technological Advancements - The market growth is driven by advancements in ultrasound technology, particularly in image processing and AI-powered analysis, including developments such as 3D and 4D imaging, elastography, and Doppler imaging [4]. - These technological improvements enhance image quality, automate measurements, and enable real-time visualization, leading to increased demand for sophisticated ultrasound image analysis software [4][5]. Regional Insights - North America is anticipated to have the highest revenue share during the forecast period due to its well-established healthcare infrastructure and high adoption of advanced imaging technologies [6]. - The Asia Pacific region is predicted to grow at the fastest CAGR, driven by an expanding healthcare sector, increasing government investments, and rising prevalence of chronic diseases in emerging markets like China and India [7]. Market Segmentation by Type - The integrated software segment accounted for the highest revenue in 2024, driven by the adoption of comprehensive diagnostic solutions that enhance workflow efficiency [8]. - The standalone software segment is expected to grow at the fastest CAGR, catering to specific clinical needs in smaller clinics and diagnostic centers [9]. Market Segmentation by Product - The Doppler imaging segment accounted for the highest revenue in 2024, widely used in vascular imaging, obstetrics, and cardiology [10]. - The 3D & 4D ultrasound systems segment is predicted to grow at the fastest CAGR due to its advanced imaging capabilities [11]. Market Segmentation by Application - The cardiology segment accounted for the highest revenue in 2024, driven by the increasing prevalence of cardiovascular diseases [12]. - The oncology segment is expected to grow at the fastest CAGR, leveraging advanced image analysis tools for cancer detection and monitoring [13]. Market Segmentation by End-User - The hospitals segment accounted for the highest revenue in 2024, attributed to high patient volume and advanced infrastructure [14]. - The diagnostic centers segment is predicted to grow at the fastest CAGR, driven by the demand for quick and accurate diagnostic solutions [16].

Core Insights - The handheld multi-parameter monitoring devices market is experiencing significant growth driven by the demand for portable and real-time health monitoring solutions [2][3] - The market was valued at US$ 3.2 billion in 2024 and is projected to grow at a CAGR of 4.6%, reaching over US$ 5.3 billion by 2035 [2][3] Market Drivers - Increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, and respiratory disorders necessitates continuous monitoring [6] - The shift towards home healthcare and remote patient monitoring is fostering personalized and decentralized healthcare solutions [6] - Advancements in sensor and wearable technologies are leading to the development of lightweight, non-invasive, and AI-integrated monitoring systems [6] - The growing geriatric population demands easy-to-use, real-time health tracking solutions [6] - The integration of telemedicine and digital health is expanding the adoption of cloud-based and Bluetooth-enabled diagnostic tools [6] Competitive Landscape - Key players in the market include Abbott, Medtronic, Koninklijke Philips N.V., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., GE HealthCare, and NIHON KOHDEN CORPORATION [7][11] - Companies are focusing on investments in sensor technology, AI-based analytics, and wireless connectivity to enhance patient monitoring experiences [7] Market Segmentation - By application, the market share is distributed as follows: Hospital & Clinical Use (40%), Home Healthcare (30%), Emergency & Critical Care (20%), and Military & Remote Healthcare (10%) [13] - By region, North America holds 45% market share, followed by Europe at 30%, Asia-Pacific at 15%, and the Rest of the World at 10% [14] Future Outlook - Emerging opportunities include portable handheld monitors for hospitals and home care, wearable multi-parameter devices integrated with smart technology, and wireless devices enabling remote monitoring [15] - The market is characterized by rapid technological advancements and increasing investments in healthcare infrastructure [9][10]